Unifontis – Integrative cancer therapies according to Prof. Dr. J. Drevs. Learn more in our therapy glossary about immunotherapies, infusions and more.https://www.unifontis.net/en/therapy-glossary/781453455.xml?limit=10https://cdn1.site-media.eu/images/0/17648139/Logo6-qtEFGoQ5FTROgRWsoCbxSA-Jzy1kdV-SZI7hQIrlCvMLA.pngenVaxo QRE® is a personalized, cell-based immunotherapy used by Prof. Dr. Joachim Drevs at Unifontis to activate the immune system in integrative cancer treatment.https://www.unifontis.net/en/glossary/vaxo-qrehttps://www.unifontis.net/en/glossary/vaxo-qreSOT therapy (Supportive Oligonukleotide-Therapy) at Unifontis uses synthetic oligonucleotides to selectively deactivate harmful cells – precise, individualized, and low in side effects.https://www.unifontis.net/en/glossary/sot-supportive-oligonucleotide-therapyhttps://www.unifontis.net/en/glossary/sot-supportive-oligonucleotide-therapyThe Universal Vaccine activates the immune system using shared tumor antigens – applied at Unifontis for individualized cancer recurrence prevention.https://www.unifontis.net/en/glossary/universal-vaccineshttps://www.unifontis.net/en/glossary/universal-vaccinesThe peptide vaccine at Unifontis uses tumor-specific peptides to activate the immune system – tailored for cancer recurrence prevention.https://www.unifontis.net/en/glossary/peptide-vaccineshttps://www.unifontis.net/en/glossary/peptide-vaccinesThe autologous vaccine at Unifontis uses patient-derived tumor material to stimulate the immune system – individually tailored and well tolerated.https://www.unifontis.net/en/glossary/autologous-vaccineshttps://www.unifontis.net/en/glossary/autologous-vaccines